Bulk drug exemption depends on qualifying formulation use; menthol I.P. cleared for cosmetics and toothpaste was ineligible.

Exemption under Notification No. 31/88-C.E. for bulk drugs depended on the definition of "bulk drugs" adopted from the Drugs (Prices Control) Order, 1987. A substance qualified only if it was used as such or as an ingredient in a "formulation," meaning a medicine for internal or external use in diagnosis, treatment, mitigation, or prevention of disease. Menthol I.P. cleared to buyers using it in toothpaste, powder, and shaving cream did not satisfy that definition, because those products were not qualifying formulations. The absence of an end-use certificate did not change the result, as the decisive issue was substantive eligibility. The exemption was therefore denied.

---

---

Issues: Whether menthol I.P. cleared to buyers using it in tooth paste, powder, and shaving cream was entitled to exemption under Notification No. 31/88-C.E. as a bulk drug.

Analysis: Notification No. 31/88-C.E. granted exemption to bulk drugs specified in the Table and adopted the meaning of "bulk drugs" from the Drugs (Prices Control) Order, 1987. Under that Order, a bulk drug is a substance conforming to prescribed standards and used as such, or as an ingredient in a formulation. "Formulation" means a medicine processed out of, or containing one or more bulk drugs or drugs, for internal or external use in the diagnosis, treatment, mitigation or prevention of disease in human beings or animals. The appellants did not dispute that the menthol I.P. was cleared to manufacturers of tooth paste, powder, and shaving cream, which are not formulations within that definition. The material was therefore not used as such, or as an ingredient in any formulation covered by the notification. The argument based on absence of an end-use certificate did not assist the appellants because the case turned on the substantive eligibility of the goods to the exemption.

Conclusion: The menthol I.P. was not eligible for exemption under Notification No. 31/88-C.E., and the finding denying the benefit was upheld in favour of Revenue.

Final Conclusion: The appeal failed because the goods did not satisfy the notification's definition-linked condition for bulk drugs, and the duty demand and related order were sustained.

Ratio Decidendi: Where an exemption notification incorporates the definition of "bulk drugs" from the Drugs (Prices Control) Order, 1987, the benefit is available only if the goods are used as such or as an ingredient in a qualifying formulation; clearance for non-qualifying end use disqualifies the exemption.

---